|
Real-time Estimate
Cboe BZX
22:19:10 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 3.575 USD | +3.92% |
|
+9.02% | -26.19% |
| 09-21 | Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to S&P Global BMI Index | CI |
| 09-11 | Relmada Therapeutics Shares Rise After CEO, CFO Buy 200,000 Shares Each | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RLMD | Delayed | |
CBOE
| RLMD | Real-time | |
|
Börse Stuttgart
| 4E2 | Delayed | |
|
Deutsche Boerse AG
| 4E2 | Delayed | |
|
Tradegate
| 4E2 | Real-time | |
|
Boerse Muenchen
| 4E2 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 3.73 | 5 | 4.52 |
| Spread/Res. | -4.42% | -28.70% | -21.13% |
| Spread/Supp. | +15.00% | +15.00% | +15.00% |
| Support | 3.1 | 3.1 | 3.1 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RLMD Stock
- Charts Relmada Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
